Enhanced myocardial fluorodeoxyglucose uptake following Adriamycin-based therapy: Evidence of early chemotherapeutic cardiotoxicity?
dc.contributor.author | Borde, C. | |
dc.contributor.author | Kand, P. | |
dc.contributor.author | Basu, Sandip | |
dc.date.accessioned | 2012-11-16T08:53:48Z | |
dc.date.available | 2012-11-16T08:53:48Z | |
dc.date.issued | 2012 | |
dc.description.division | RMC | en |
dc.format.extent | 5619 bytes | |
dc.format.mimetype | text/html | |
dc.identifier.source | World journal of radiology, 2012. Vol. 4 (5): pp. 220-223 | en |
dc.identifier.uri | http://hdl.handle.net/123456789/6816 | |
dc.language.iso | en | en |
dc.subject | Adriamycin | en |
dc.subject | Cardiotoxicity | en |
dc.subject | 18F-fluorodeoxyglucose | en |
dc.subject | Heart failure | en |
dc.subject | Positron emission tomography | en |
dc.title | Enhanced myocardial fluorodeoxyglucose uptake following Adriamycin-based therapy: Evidence of early chemotherapeutic cardiotoxicity? | en |
dc.type | Article | en |